Hansen-Algenstaedt, N <br/><br/>
Tumor oxygenation in hormone-dependent tumors during vascular endothelial growth factor receptor-2 blockade, hormone ablation, and chemotherapy.  [electronic resource] 

 -  Cancer research  Aug 2000 
 - 4556-60 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Androgens--physiology<br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Antibodies, Monoclonal--immunology<br/>Antineoplastic Combined Chemotherapy Protocols--pharmacology<br/>Cyclophosphamide--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Luminescent Measurements<br/>Male<br/>Mammary Neoplasms, Experimental--blood supply<br/>Mice<br/>Mice, SCID<br/>Microscopy, Fluorescence--methods<br/>Neoplasm Transplantation<br/>Neoplasms, Hormone-Dependent--blood supply<br/>Orchiectomy<br/>Oxygen--blood<br/>Oxygen Consumption<br/>Partial Pressure<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptors, Growth Factor--antagonists & inhibitors<br/>Receptors, Vascular Endothelial Growth Factor